Pharmaceutical Market Europe • April 2022 • 3
COMMENT
In our cover article this month, Danny Buckland looks at how how insights from patients and HCPs are powering a new era of launch excellence. As Danny explains, the previous certainty around launches – the preparation, research, message testing and then the final countdown that all followed a measured path – has been changed by the huge disruption caused by the pandemic.
He goes on to say that, despite this, a new suite of digital channels and engagement strategies has emerged, and the prime objective of keeping healthcare professionals and patients at the heart of mission control remains. Read more on page 26.
Also in this month’s issue, we have a holistic strategy article – Lessons from a pandemic.
Implementing a holistic strategy can be frustrating or impossible, and COVID-19 has delivered a scenario where developing the strategy for any brand is a challenge. Read more on page 34.
Our article on brand planning on page 36 looks at why pharma marketing teams need to embrace new age social intelligence or risk being left behind, and why brand planners must pay more attention to the voice of the patient, ensuring those insights are at the heart of brand strategies and marketing-led interventions.
Looking ahead, our May issue will look at how COVID-19 has renewed the focus on behaviour change. The COVID-19 pandemic has brought a sharp focus to the importance of behaviour change. But behaviour is complex and the factors that trigger our decision-making are human, personal and nuanced. So how do you encourage people to take steps to change their behaviour?
If you would like to make your voice heard on this topic, please get in touch at sales@pmlive.com
I hope you enjoy this issue!
Iona Everson
Group Managing Editor
Keep up to date with the latest developments in the UK and global healthcare marketplace – sign up to daily or weekly news alerts and fortnightly or monthly bulletins on specific topics at www.pmlive.com/register
THE TEAM
Editorial:
Group Managing Editor
Iona Everson
Journalist/editorial assistant
Fleur Jeffries
Studio:
Executive Director
Karl Equi
Sales:
Business Director
Tara Lovegrove
EDITORIAL ADVISORY BOARD
Philip Atkinson
Founder of Hive-Logic, Lifescience Transformation
Uday Bose
Corporate vice president, head of global marketing oncology, Boehringer Ingelheim
Dr Luc Hermans
VP commercial planning and operations Europe, Asia, Middle East, Gilead Sciences
Stefan Janssens
President EMEA, Cegedim Dendrite
John Morris
Partner, KPMG
Paul Pay
Chief business development officer, Norgine
Mark Rothera
Chief executive officer, Orchard Therapeutics
Ian Talmage
Senior vice president, global marketing, general medicine, Bayer Pharmaceuticals
PUBLISHED BY
PMGroup
Mansard House, Church Road, Little Bookham, Surrey, KT23 3JG, UK
Tel: +44 (0)1372 414200
Fax: +44 (0)1372 414201
CONTACT US
General enquiries: info@pmlive.com
Editorial: editor@pmlive.com
Advertising: sales@pmlive.com
Subscriptions: subscriptions@pmlive.com
Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.
© 2022 PMGroup
All rights reserved. No part of this publication may be copied, reproduced, transmitted, photocopied, recorded or stored on any retrieval system without the prior written consent of the publishers.
The magazine is also available at the following subscription rates: £120 UK, £180 Europe, £210 RoW